Exploring the Future of Cancer Diagnostics: Insights from the 2025 AVBCC Summit Cizzle Bio's CEO, Bill Behnke, moderated a key panel focused on innovative cancer diagnostics at the 2025 AVBCC Summit, addressing critical topics in oncology.

Exploring the Future of Cancer Diagnostics: Insights from the 2025 AVBCC Summit #United_States #New_York #Cizzle_Bio #Bill_Behnke #AVBCC_Summit

Cizzle Bio Celebrates Collaboration for Cancer Awareness at Prevent Cancer Foundation Gala Cizzle Bio, a leader in cancer diagnostic innovation, sponsors the Prevent Cancer Foundation Gala, supporting early detection efforts and honoring cancer advocates.

Cizzle Bio Celebrates Collaboration for Cancer Awareness at Prevent Cancer Foundation Gala #United_States #Washington,_D.C. #Cancer_Research #Cizzle_Bio #Prevent_Cancer_Foundation

Cizzle Bio CEO Bill Behnke Honored as Most Inspiring Business Leader 2025 by CXO Outlook Bill Behnke, CEO of Cizzle Bio, has been recognized as the Most Inspiring Business Leader 2025 by CXO Outlook for his innovations in cancer detection.

Cizzle Bio CEO Bill Behnke Honored as Most Inspiring Business Leader 2025 by CXO Outlook #United_States #San_Antonio #cancer_detection #Cizzle_Bio #Bill_Behnke

Groundbreaking Study Validates DEX-G2 Blood Test for Early Gastric Cancer Detection A recent clinical study published in JAMA Surgery highlights the diagnostic efficacy of Cizzle Bio's DEX-G2 blood test, pivotal for early gastric cancer detection.

Groundbreaking Study Validates DEX-G2 Blood Test for Early Gastric Cancer Detection #United_States #San_Antonio #gastric_cancer #Cizzle_Bio #DEX-G2

Cizzle Bio Partners with Top Institutes for Lung Cancer Detection Research Grant Submission Cizzle Bio has submitted an NIH grant proposal in collaboration with leading research institutions to validate its CIZ1B biomarker blood test for early lung cancer detection.

Cizzle Bio Partners with Top Institutes for Lung Cancer Detection Research Grant Submission #United_States #San_Antonio #Lung_Cancer #Cizzle_Bio #CIZ1B

Cizzle Bio Expands Global Presence with Innovative Cancer Blood Tests in the Cayman Islands Cizzle Bio has launched its innovative biomarker blood tests for lung and gastric cancers in the Cayman Islands, partnering with Doctors Hospital.

Cizzle Bio Expands Global Presence with Innovative Cancer Blood Tests in the Cayman Islands #cancer_testing #Cayman_Islands #George_Town #Biomarkers #Cizzle_Bio

Cizzle Bio's CIZ1B Test Could Save Medicare $518 Million Annually Thanks to Early Lung Cancer Detection Cizzle Bio's innovative CIZ1B biomarker test for lung cancer could potentially save Medicare up to $518 million each year by enhancing early detection rates.

Cizzle Bio's CIZ1B Test Could Save Medicare $518 Million Annually Thanks to Early Lung Cancer Detection #United_States #Chicago #Lung_Cancer #Cizzle_Bio #CIZ1B